First infusions with Eteplirsen orphan medicine from Qazaqstan Khalqyna fund reimbursement for new DMD patients in Kazakhstan.

2 new patients started therapy with Eteplirsen in June 2023.
#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #CentralAsia #SareptaTherapeutics #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany